Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pfister

Showing results (41-50 of 194) with videos related to

Pageof 20
Sort By:
Aktuelle Urologie|January 17, 2024
[Palliative urologic surgery for metastatic prostate cancer: what needs to be considered in the future?]Axel Heidenreich, Christian Bach, David Pfister
Journal of Chromatography. A|April 16, 2016
A continuum theory for multicomponent chromatography modelingDavid Pfister, Massimo Morbidelli, Roger-Marc Nicoud
Aktuelle Urologie|February 7, 2014
[Hypogonadism - testosterone replacement therapy after prostate cancer?]Julius van Essen, David Pfister, Axel Heidenreich
BJU International|July 2, 2010
Percentage of positive biopsies predicts lymph node involvement in men with low-risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomyAxel Heidenreich, David Pfister, David Thüer, et al.
Urology|February 21, 2012
A continent urinary diversion in a female with agenesis of the bladder: a 5-year follow-upDavid Pfister, Dina Sahi, Axel Heidenreich, et al.
European Urology|May 28, 2013
Castration-resistant prostate cancer: where we stand in 2013 and what urologists should knowAxel Heidenreich, David Pfister, Axel Merseburger, et al.
Oncology Research and Treatment|May 18, 2018
Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular CancerAxel Heidenreich, Pia Paffenholz, Tim Nestler, et al.
Current Opinion in Urology|March 20, 2021
Salvage radical prostatectomy after local radiotherapy in prostate cancerDavid Pfister, Ruud Kokx, Florian Hartmann, et al.
Archivos Espanoles De Urologia|March 12, 2019
Management of positive lymph nodes following radical prostatectomyAxel Heidenreich, Milena Rieke, Sammy Mahjoub, et al.
Expert Review of Anticancer Therapy|February 23, 2019
Management of residual masses in testicular germ cell tumorsAxel Heidenreich, Pia Paffenholz, Tim Nestler, et al.
Pageof 20

Showing results (41-50 of 194) with videos related to

Sort By:
Pageof 20
Aktuelle Urologie|January 17, 2024
[Palliative urologic surgery for metastatic prostate cancer: what needs to be considered in the future?]Axel Heidenreich, Christian Bach, David Pfister
Journal of Chromatography. A|April 16, 2016
A continuum theory for multicomponent chromatography modelingDavid Pfister, Massimo Morbidelli, Roger-Marc Nicoud
Aktuelle Urologie|February 7, 2014
[Hypogonadism - testosterone replacement therapy after prostate cancer?]Julius van Essen, David Pfister, Axel Heidenreich
BJU International|July 2, 2010
Percentage of positive biopsies predicts lymph node involvement in men with low-risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomyAxel Heidenreich, David Pfister, David Thüer, et al.
Urology|February 21, 2012
A continent urinary diversion in a female with agenesis of the bladder: a 5-year follow-upDavid Pfister, Dina Sahi, Axel Heidenreich, et al.
European Urology|May 28, 2013
Castration-resistant prostate cancer: where we stand in 2013 and what urologists should knowAxel Heidenreich, David Pfister, Axel Merseburger, et al.
Oncology Research and Treatment|May 18, 2018
Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular CancerAxel Heidenreich, Pia Paffenholz, Tim Nestler, et al.
Current Opinion in Urology|March 20, 2021
Salvage radical prostatectomy after local radiotherapy in prostate cancerDavid Pfister, Ruud Kokx, Florian Hartmann, et al.
Archivos Espanoles De Urologia|March 12, 2019
Management of positive lymph nodes following radical prostatectomyAxel Heidenreich, Milena Rieke, Sammy Mahjoub, et al.
Expert Review of Anticancer Therapy|February 23, 2019
Management of residual masses in testicular germ cell tumorsAxel Heidenreich, Pia Paffenholz, Tim Nestler, et al.
Pageof 20